BCL2 marker impacts on chemotherapy to breast cancer patients: Research
 

A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists.The study, part-funded by Cancer Research UK and published in the British Journal of Cancer today (Wednesday), shows for the first time how this molecular marker has been singled out as an independent factor in examining a breast cancer patient's tumour.

More...

Re: BCL2 marker impacts on chemotherapy to breast cancer patients: Research
 

Thank you, this is very interesting!